Phase III Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis: ORATORIO Study Design

被引：0
作者：
Montalban, Xavier
Wolinsky, Jerry
Yin, Ming
Leppert, David
Glanzman, Robert
Chin, Peter
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A319 / A320
页数：2
相关论文
共 50 条
[31]   Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis [J].
Hauser, Stephen L. ;
Kappos, Ludwig ;
Montalban, Xavier ;
Craveiro, Licinio ;
Hughes, Richard ;
Prajapati, Kalpesh ;
Koendgen, Harold ;
Pradhan, Ashish ;
Wolinsky, Jerry S. .
NEUROLOGY, 2020, 94 (15)
[32]   Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis [J].
Hauser, S. L. ;
Kappos, L. ;
Montalban, X. ;
Craveiro, L. ;
Hughes, R. ;
Prajapati, K. ;
Koendgen, H. ;
Pradhan, A. ;
Wolinsky, J. S. .
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 :331-331
[33]   SOCIOECONOMIC VALUE OF OCRELIZUMAB IN THE TREATMENT OF PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS [J].
Di Maio, D. ;
Liu, C. ;
Marcelli, G. ;
Alvarez, Sanchez J. ;
Overell, J. .
VALUE IN HEALTH, 2020, 23 :S632-S633
[34]   Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis [J].
Hauser, Stephen L. ;
Kappos, Ludwig ;
Montalban, Xavier ;
Guittari, Carol-Jean ;
Koendgen, Harold ;
Li, Carrie ;
Marcillat, Carole ;
Wormser, David ;
Wolinsky, Jerry .
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) :NP13-NP13
[35]   Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis [J].
Hauser, S. L. ;
Kappos, L. ;
Montalban, X. ;
Hughes, R. ;
McNamara, J. ;
Pradhan, A. ;
Wormser, D. ;
Koendgen, H. ;
Wolinsky, J. S. .
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 :239-239
[36]   Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis [J].
Hauser, Stephen ;
Kappos, Ludwig ;
Montalban, Xavier ;
Chognot, Cathy ;
Jessop, Nikki ;
Kadner, Karen ;
Pradhan, Ashish ;
Incera, Elodie ;
Wolinsky, Jerry .
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 :352-353
[37]   Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis [J].
Hauser, S. ;
Kappos, L. ;
Montalban, X. ;
Chognot, C. ;
Craveiro, L. ;
Pradhan, A. ;
Prajapati, K. ;
Wolinsky, J. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :306-306
[38]   Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis [J].
Hauser, S. L. ;
Kappos, L. ;
Montalban, X. ;
Chognot, C. ;
Jessop, N. ;
Kadner, K. ;
Pradhan, A. ;
Prajapati, K. ;
Wolinsky, J. S. .
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) :354-355
[39]   Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis [J].
Hauser, Stephen L. ;
Kappos, Ludwig ;
Montalban, Xavier ;
Hughes, Richard ;
McNamara, John ;
Pradhan, Ashish ;
Wormser, David ;
Koendgen, Harold ;
Wolinsky, Jerry S. .
NEUROLOGY, 2019, 92 (15)
[40]   Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis [J].
Hauser, S. L. ;
Kappos, L. ;
Montalban, X. ;
Hughes, R. ;
Koendgen, H. ;
McNamara, J. ;
Pradhan, A. ;
Wormser, D. ;
Wolinsky, J. S. .
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 :697-698
12345